In the literature, the occurrence of mainly gastrointestinal and hematological effects during treatment for ALL is evidenced and is mainly associated with genetic variations in genes such as NUDT15, TPMT, and PDE4D causing more severe toxicities in certain ethnic groups such as the Amerindians [15,22,23]. This evidence concerns the gene TPMT and acute lymphoblastic leukemia.